| ||||||||||||||||||||||
|
||||||||||||||||||||||
| Security Type | Common Stock | Specialist | 076 | |
| Industry | Health Services, Pharmaceuticals, and Medical Diagnostics | Trading Post | 2 | |
| Primary Exchange | NYSE Amex | SEC Filings | ||
| Description |
|
Lannett Company, Inc. develops, manufactures, markets, and distributes generic versions of pharmaceutical products in the United States. Its products portfolio primarily includes Acetazolamide tablets for glaucoma; Baclofen tablets for muscle relaxation; Bethanechol Chloride tablets for urinary retention; Butalbital, Aspirin, Caffeine with Codeine Phosphate capsules to treat migraine headache; Clindamycin HCl capsules, Doxycycline tablets, Doxycycline Hyclate tablets used as antibiotics; Danazol capsules for endometriosis; Dicyclomine tablets/capsules for irritable bowels; Digoxin tablets to treat congestive heart failure; and Diphenoxylate with Atropine Sulfate tablets for Diarrhea. The company also offers Hydromorphone HCl tablets, Morphine Sulfate oral solution, and Oxycodone HCl oral solution for pain management; Levothyroxine Sodium tablets to treat thyroid deficiency; Methyltestoterone/Esterified Estrogens tablets used in hormone replacement; Phentermine HCl tablets/capsules for weight loss; Pilocarpine HCl tablets to treat dryness of the mouth; Primidone tablets for epilepsy; Probenecid tablets for gout; Sulfamethoxazole with Trimethoprim used as antibacterial; Terbutaline Sulfate tablets for bronchospasms; and Unithroid tablets to treat thyroid deficiency. Lannett Company sells its pharmaceutical products to generic pharmaceutical distributors, drug wholesalers, chain drug retailers, private label distributors, mail-order pharmacies, other pharmaceutical manufacturers, managed care organizations, hospital buying groups, and health maintenance organizations. It has supply and development agreements with Olive Healthcare of India; Orion Pharma of Finland; Azad Pharma AG of Switzerland; Unichem, Inc. of India; Wintac Limited of India; Pharmaseed in Israel; and Banner Pharmacaps and Catalent of the United States. The company was founded in 1942 and is based in Philadelphia, Pennsylvania. |
| Quote |
| Last Sale | $6.40 (11/20/09) | |||
| Net Change | 1.45 | |||
| % Change | 29.29 | |||
| Previous Close | $4.95 | |||
| Today’s Open | $4.95 | |||
| Today’s High | $6.91 | |||
| Today’s Low | $4.74 | |||
| Volume | 209,299 | |||
| 52 Week High | $9.74 | |||
| 52 Week Low | $1.50 | |||
| Chart |
| 3mo | 6mo | 12mo | 24mo | 36mo | 48mo | 60mo |
|
| Click here to view the data behind the chart. |
| Fundamentals |
| P/E ratio | 14.56 | Short Interest | 217,151 | |
| Earnings Per Share | 0.33 | Current yield | N.A. | |
| Shares Outstanding | 24,699,000 | Dividend Info | ||
| Market Cap | 158,073,600 | |||